Identifying baseline rectal MRI features as predictive indicators for local recurrence and metastatic disease in rectal cancer treated with surgical resection and neoadjuvant therapy or surgical resection alone
Maria El Homsi(Memorial Sloan Kettering Cancer Center), Iva Petkovska(Beth Israel Deaconess Medical Center), Sidra Javed-Tayyab(Memorial Sloan Kettering Cancer Center), Charlie White(Memorial Sloan Kettering Cancer Center), Natalie Gangai(Memorial Sloan Kettering Cancer Center), Viktoriya Paroder(Memorial Sloan Kettering Cancer Center), Jennifer S. Golia Pernicka(Memorial Sloan Kettering Cancer Center), Marinela Capanu(Memorial Sloan Kettering Cancer Center), Lee Rodriguez(Memorial Sloan Kettering Cancer Center), Charlotte Charbel(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: <i>Radiology</i> Scientific Expert Panel
|Radiology|2021|135
MRI for Rectal Cancer: Staging, mrCRM, EMVI, Lymph Node Staging and Post-Treatment Response
|Clinical Colorectal Cancer|2021|81
Review of chest CT manifestations of COVID-19 infection
|European Journal of Radiology Open|2020|68
Precision of MRI radiomics features in the liver and hepatocellular carcinoma
|European Radiology|2021|41